Xiang Li

Dr. Xiang Li


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
XLXiru Liu
Xiru Liu
HZHao Zhang
Hao Zhang
JYJinxiao Yan
Jinxiao Yan
XLXiang Li
Xiang Li
JLJie Li
Jie Li
HYHui Yang
Hui Yang
Hypoxic exposure makes plateau migrators susceptible to high altitude polycythemia (HAPC). Astragalus membranaceus (AM) is an edible and medicinal plant with remarkable immunomodulatory activities. The purpose of this study was to discover if AM could be a candidate for the prevention of HAPC and its mechanism. Here, network pharmacology was applied to screen active compounds, key targets, and enriched pathways of AM in the treatment of HAPC. Molecular docking evaluated the affinity between compounds and core targets. Subsequently, the mechanisms of AM were further verified using the hypoxia exposure-induced mice model of HAPC. The network pharmacology analysis and molecular docking results identified 14 core targets of AM on HAPC, which were predominantly mainly enriched in the HIF-1 pathway. In the HAPC animal models, we found that AM inhibited the differentiation of hematopoietic stem cells into the erythroid lineage. It also suppressed the production of erythrocytes and hemoglobin in peripheral blood by reducing the expression of HIF-1α, EPO, VEGFA, and Gata-1 mRNA. Furthermore, AM downregulated the expression of IL-6, TNF-α, and IFN-γ mRNA, thereby alleviating organ inflammation. In conclusion, AM supplementation alleviates hypoxia-induced HAPC in mice, and TNF-α, AKT1, HIF-1α, VEGFA, IL-6, and IL-1B may be the key targets.

1 April 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
XLXiang Li
Xiang Li
JCJing Chang
Jing Chang
QXQingxin Xia
Qingxin Xia
JYJinxiao Yan
Jinxiao Yan
HZHe Zhang
He Zhang
HYHui Yang
Hui Yang
The tumor microenvironment (TME) is a highly dynamic and heterogeneous system composed of tumor cells, stromal cells and non-cellular components that collectively govern tumor initiation, progression, and metastasis. Beyond host-derived components, accumulating evidence has established that microorganisms are integral constituents of the TME. These tumor-associated microbes not only affect tumor cells directly but also reshape the TME. Importantly, microbial-driven remodeling of the TME is accompanied by changes in its biomechanical properties. These alterations introduce a biophysical dimension of the TME that operates alongside biochemical signaling. Studies have shown that certain microorganisms reshape mechanotransduction pathways within tumor cells. Such biomechanical alterations enhance tumor cell adaptability to shear stress, promote survival in circulation, and facilitate invasion and colonization at distant sites. Although direct evidence linking microbes to specific biomechanical changes in tumors remains limited, these preliminary insights point to a largely unexplored yet highly promising frontier. This review explores the physical properties of the TME and delineates the association between microorganisms and the dynamics of these physical signals. It then examines strategies for leveraging microorganisms in tumor therapy. Understanding these interactions may reveal novel therapeutic targets to harness microbial influences and inhibit tumor progression.